Finance

Lists
524816:BOM
Natco Pharma Ltd
786,60 ₹
+0,23%
(+1,80) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524816...
Open
786,10 ₹
High
788,50 ₹
Low
781,00 ₹
Mkt. cap
154,16 млрд
Avg. vol.
36,95 мың
Volume
9,52 мың
Dividend
0,57%
Quarterly dividend
1,12 ₹
Ex-dividend date
2026 ж. 20 там.
P/E ratio
12,41
52-wk high
1 216,20 ₹
52-wk low
780,00 ₹
EPS
63,37 ₹
Shares outstanding
182,26 млн
No. of employees
4 мың
Open
786,10 ₹
High
788,50 ₹
Low
781,00 ₹
Mkt. cap
154,16 млрд
Avg. vol.
36,95 мың
Volume
9,52 мың
Dividend
0,57%
Quarterly dividend
1,12 ₹
Ex-dividend date
2026 ж. 20 там.
P/E ratio
12,41
52-wk high
1 216,20 ₹
52-wk low
780,00 ₹
EPS
63,37 ₹
Shares outstanding
182,26 млн
No. of employees
4 мың
News stories
From web sources and news partners
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4,43 мың
Founded1981
HeadquartersBanjara Hills, Телингана, Үндістан
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
13,63 млрд
6,47 млрд
7,43 млрд
7,35 млрд
Cost of goods sold
1,70 млрд
1,33 млрд
1,99 млрд
1,48 млрд
Cost of revenue
1,70 млрд
1,33 млрд
1,99 млрд
1,48 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,00 млрд
1,59 млрд
1,63 млрд
1,79 млрд
Operating expense
6,66 млрд
4,02 млрд
4,38 млрд
4,48 млрд
Total operating expenses
8,36 млрд
5,35 млрд
6,37 млрд
5,96 млрд
Operating income
5,27 млрд
1,12 млрд
1,06 млрд
1,39 млрд
Other non operating income
1,00 млрд
581,00 млн
-2,11 млрд
592,00 млн
EBT including unusual items
6,14 млрд
1,72 млрд
1,80 млрд
2,70 млрд
EBT excluding unusual items
6,14 млрд
1,72 млрд
2,02 млрд
2,70 млрд
Income tax expense
958,00 млн
207,00 млн
-892,00 млн
634,00 млн
Effective tax rate
15,61%
12,03%
-49,61%
23,49%
Other operating expenses
4,14 млрд
1,96 млрд
2,23 млрд
2,22 млрд
Net income
5,18 млрд
1,52 млрд
2,68 млрд
2,06 млрд
Net profit margin
38,03%
23,40%
36,08%
28,09%
Earnings per share
28,94
8,46
14,96
11,53
Interest and investment income
-
-
2,33 млрд
-
Interest expense
-131,00 млн
-95,00 млн
-
-130,00 млн
Net interest expenses
-131,00 млн
-95,00 млн
2,33 млрд
-130,00 млн
Depreciation and amortization charges
524,00 млн
462,00 млн
504,00 млн
471,00 млн
EBITDA
5,82 млрд
1,57 млрд
1,55 млрд
1,91 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары